From FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy:

Evrysdi-Approval-Product-Shot_FINAL-Medium-copy
Evrysdi-Approval-Product-Shot_FINAL-Medium-copy

Image courtesy of Genentech